Table of Contents Table of Contents
Previous Page  167 / 220 Next Page
Information
Show Menu
Previous Page 167 / 220 Next Page
Page Background

165

Note 1 Significant Accounting Policies

(continued)

m) Cash and cash equivalents:

Cash and cash equivalents include cash in hand, demand deposits with bank and other short-term (three months or less

from the date of acquisition), highly liquid investments that are readily convertible into cash and which are subject to an

insignificant risk of changes in value.

n) Trade receivables:

Trade receivables are initially recognised at fair value. Subsequently, these assets are held at amortised cost, using the

effective interest rate method (EIR), less provision for impairment based on expected credit loss.

o) Trade and other payables:

These amounts represent liabilities for goods and services provided to the Group prior to the end of financial year which

are unpaid. Trade and other payables are presented as current liabilities unless payment is not due within 12 months after

the reporting period. They are recognised initially at their fair value and subsequently measured at amortised cost using the

EIR method.

p) Inventories:

Inventories (other than harvested product of biological assets) are stated at cost or net realisable value, whichever is lower.

Cost is arrived at moving weighted average basis.

Cost comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventory to the present

location and condition. Cost includes the reclassification from equity of any gains or losses on qualifying cash flow hedges

relating to purchases of raw material, but excludes borrowing costs.

Due allowances are made for slow moving and obsolete inventories based on estimates made by the Group.

Items such as spare parts, stand-by equipment and servicing equipment which are not property, plant and machinery get

classified as inventory.

The harvested product of biological assets of the Group is initially measured at fair value less costs to sell on the point of

harvest and subsequently measured at the lower of such value or net realisable value.

q) Investments and other financial assets:

Classification:

The Group classifies its financial assets in the following measurement categories:

i)

Those to be measured subsequently at fair value (either through Other Comprehensive Income, or through profit

or loss)

ii) Those measured at amortised cost

The classification depends on business model of the Group for managing the financial assets and the contractual terms of

the cash flows.

For assets measured at fair value, gains and losses will either be recorded in profit or loss or Other Comprehensive Income.

For investments in debt instruments, this will depend on the business model in which the investment is held. For investments

in equity instruments, this will depend on whether the Group has made an irrevocable election at the time of initial

recognition to account for the equity investments at fair value through Other Comprehensive Income.

Initial recognition and measurement:

Financial asset is recognised when the Group becomes a party to the contractual provisions of the instrument. Financial

asset is recognised initially at fair value plus, in the case of financial asset not recorded at fair value through profit or loss,

transaction costs that are attributable to the acquisition of the financial asset. Transaction costs of financial asset carried at

fair value through profit or loss are expensed in the Consolidated Statement of Profit and Loss.

Subsequent measurement:

After initial recognition, financial asset is measured at:

i)

fair value (either through Other Comprehensive Income or through profit or loss) or,

ii) amortised cost.

Debt instruments:

Subsequent measurement of debt instruments depends on the business model of the Group for managing the asset and

the cash flow characteristics of the asset. There are three measurement categories into which the Group classifies its debt

instruments:

Notes

to the Consolidated Financial Statements